BioClinica told investors that it won't be issuing annual guidance for 2013. That's because the provider of clinical trials software and core lab imaging is being bought in a $123 million private equity deal.
Cancer patients might fail to follow their doctor's orders often. But how often do they forget their mobile phones?
A horde of coding geeks has overtaken outdated algorithms for immunology studies, authoring software for analyzing immune-related genes faster than previous systems, Nature reported on a news blog.
With more than 1 billion users plugged in, Facebook has huge potential to have a real impact on science and public health, beyond just a marketing platform for biotech and pharma companies.
Tech giant Oracle has found another taker for its new software designed to help pharma outfits tackle clinical trials budgeting and planning.
The biotech landscape is covered with startup efforts with cancer drugs, but when Dr. Patrick Soon-Shiong announces one, the business world stops and listens.
As drug giants upend their established ways of doing drug research, companies have changing needs within their workforces. And bioinformatics expertise rose to among the top skills in demand among biopharma companies in pursuit of new therapies, PwC reported.
U.K. cancer researchers have set up a new facility to harness Big Data on tumor genes and understand how to attack malignancies, InformationWeek reported.
German drugmaker Boehringer Ingelheim has bolstered its efforts in the respiratory disease arena with a new mobile app that healthcare pros can tap during exams on patients with smoker's cough.
The New York-based private equity player JLL Partners has struck a deal to buy the growing eClinical outfit BioClinica for $7.25 per share or about $123 million, paying a 23.2% premium on the average closing price of the company's stock for the past 90 days.
Is genome interpretation approaching "bubble" status as startups rise all around to find what matters in massive amounts of DNA data? Bio-IT World editor and genomics chronicler Kevin Davies questioned the chief executive of one of the higher-profile outfits from the field, Cypher Genomics, to find out what makes the startup stand out from the crowd.
In the latest push to better predict, diagnose and monitor Parkinson's disease, the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, is launching a new online collaborative resource that will support data-sharing in an effort to find biomarkers for the disease.
Philadelphia has hatched a startup with ambitious goals for improving how investigators and companies keep in touch during clinical trials. With customers and a third version of its web-based software out the door, myClin has grown out of shared office space in Old City and moved to its own office in a nearby location, MedCity News reported.
Fresh data have emerged in the ongoing debate over the regulation of medical apps for smartphones and mobile devices. Researchers questioned the accuracy of four apps for evaluating skin lesions in a study, generating some troubling results and pointing out that such apps have gone unregulated.
Facing the ugly end of a hype cycle, Big Data could turn skeptics into believers with a new initiative to improve treatment of a childhood brain cancer.
As flu infiltrates our homes and workplaces, researchers have developed a computer-based method of tracking Twitter posts that could alert the public to sickness faster than official health reports with greater accuracy than existing online tools.
Behind the huge and scary numbers that accompany the costs of drug development, there are various holes and dysfunctional practices in the process of bringing a new drug to market.
Entrepreneurs keep mining for gold with new apps that help clinics and labs overwhelmed with genomic data. Syapse has struck a venture deal with The Social+Capital Partnership, raising $3 million from the firm in a Series A round as the company mounts a big push to address the growing needs of physicians grappling with "omics" data.
Twitter has found a lukewarm reception among European Union countries' healthcare regulators, yet the U.K.'s Medical and Healthcare products Regulatory Agency (MHRA) has recently stepped up its efforts to reach the growing number of people on the social networking sites.
The CRO giant Parexel International ($PRXL) announced a changing of the guard at its Perceptive Informatics unit, which provides electronic clinical trials (eClinical) software. Healthcare software veteran Xavier Flinois is taking over for Steve Kent as president of Perceptive, the parent company said this morning.